Vanessa Broadhurst
CIK: 0001904787
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Jul 20, 2026JNJ
JOHNSON & JOHNSON
Sale(S)Direct23.1K shares at avg. $251.27$5.8M - Jul 20, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct11.1K shares at avg. $129.51$1.4M - Jul 20, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct11.9K shares at avg. $131.94$1.6M - Feb 19, 2026ZTS
Zoetis Inc.
Exercise(M)Direct1.6K shares- - Feb 19, 2026ZTS
Zoetis Inc.
Other(J)Direct517 shares at avg. $127.28$66K - Feb 18, 2026ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.9K shares- - Feb 17, 2026JNJ
JOHNSON & JOHNSON
Sale(S)Direct6.2K shares at avg. $243.39$1.5M - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct270 shares at avg. $243.45$66K - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct492 shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct526 shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectRestricted Share Units
1K shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectEmployee Stock Options (Right to Buy)
14.4K shares- - Feb 15, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct252 shares at avg. $243.45$61K - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct3.7K shares at avg. $244.55$917K - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct408 shares- - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Exercise(M)Direct8.6K shares- - Feb 13, 2026JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct144 shares at avg. $244.55$35K - Feb 9, 2026JNJ
JOHNSON & JOHNSON
Award(A)DirectPerformance Share Units
8.6K shares- - Jul 25, 2025ZTS
Zoetis Inc.
Exercise(M)Direct1.4K shares- - Jul 25, 2025ZTS
Zoetis Inc.
Other(J)Direct451 shares at avg. $152.12$69K - Feb 19, 2025ZTS
Zoetis Inc.
Award(A)DirectRestricted Stock Unit
1.6K shares- - Feb 18, 2025JNJ
JOHNSON & JOHNSON
Tax Payment(F)Direct158 shares at avg. $156.15$25K - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Award(A)DirectRestricted Share Units
1.6K shares- - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Award(A)DirectEmployee Stock Options (Right to Buy)
25.5K shares- - Feb 15, 2025JNJ
JOHNSON & JOHNSON
Exercise(M)Direct492 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 20, 2026 | JNJ JOHNSON & JOHNSON | Sale(S) | 23,054 | $251.27 | $5,792,686 | Direct |
| Jul 20, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 11,129 | $129.51 | $1,441,317 | Direct |
| Jul 20, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 11,925 | $131.94 | $1,573,385 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Exercise(M) | 1,619 | - | $0 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Other(J) | 517 | $127.28 | $65,804 | Direct |
| Feb 18, 2026 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,936 | - | - | Direct |
| Feb 17, 2026 | JNJ JOHNSON & JOHNSON | Sale(S) | 6,197 | $243.39 | $1,508,288 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 270 | $243.45 | $65,732 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 492 | - | $0 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 526 | - | $0 | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Restricted Share Units | 1,034 | - | - | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Employee Stock Options (Right to Buy) | 14,405 | - | - | Direct |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 252 | $243.45 | $61,349 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 3,748 | $244.55 | $916,573 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 408 | - | $0 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Exercise(M) | 8,594 | - | $0 | Direct |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 144 | $244.55 | $35,215 | Direct |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | Award(A) Performance Share Units | 8,594 | - | - | Direct |
| Jul 25, 2025 | ZTS Zoetis Inc. | Exercise(M) | 1,412 | - | - | Direct |
| Jul 25, 2025 | ZTS Zoetis Inc. | Other(J) | 451 | $152.12 | $68,606 | Direct |
| Feb 19, 2025 | ZTS Zoetis Inc. | Award(A) Restricted Stock Unit | 1,596 | - | - | Direct |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | Tax Payment(F) | 158 | $156.15 | $24,672 | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Award(A) Restricted Share Units | 1,576 | - | - | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Award(A) Employee Stock Options (Right to Buy) | 25,538 | - | - | Direct |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | Exercise(M) | 492 | - | - | Direct |
1-25 of 34 transactions
About Broadhurst Vanessa
Broadhurst Vanessa (SEC CIK 0001904787) files insider reports with the SEC as EVP, Global Corp Affairs of JOHNSON & JOHNSON (JNJ) and Director of Zoetis Inc. (ZTS).
Signal8 holds 11 ownership filings by Broadhurst Vanessa, all Form 4s, filed between Feb 10, 2025 and Jul 21, 2026. Those filings report 34 transactions, from Feb 6, 2025 to Jul 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Broadhurst Vanessa's filings is in NEW BRUNSWICK, NJ.
Recent filings by Broadhurst Vanessa
- Jul 20, 2026: Open-market sale of JNJ shares (Form 4, code S).
- Jul 20, 2026: Option exercises of JNJ shares (2 lines, Form 4, code M).
- Feb 19, 2026: Option exercise of ZTS shares (Form 4, code M).
- Feb 19, 2026: Other transaction of ZTS shares (Form 4, code J).
- Feb 18, 2026: Grant or award of ZTS derivative securities (Form 4, code A).
Other insiders filing for JOHNSON & JOHNSON (JNJ)
- Pinto Daniel E, Director
- Woods Eugene A., Director
- HEWSON MARILLYN A, Director
- Schmid Timothy, EVP, WW Chair, MedTech
- Cavanaugh Thomas, EVP WW Chair, Innovative Med.
- Taubert Jennifer L, EVP, WWC. Innovative Medicine